RONA Therapeutics
RONA Therapeutics develops oligonucleotide therapeutics to treat metabolic diseases, neurological diseases, and ophthalmology conditions. The company focuses on the discovery and development of modular and programmable RNA medicines using proprietary delivery systems that enable targeted delivery of RNA-based therapeutics to specific tissues and cell types. Founded in 2021 and headquartered in Shanghai, China, RONA…
Funding snapshot
About
RONA Therapeutics develops oligonucleotide therapeutics to treat metabolic diseases, neurological diseases, and ophthalmology conditions. The company focuses on the discovery and development of modular and programmable RNA medicines using proprietary delivery systems that enable targeted delivery of RNA-based therapeutics to specific tissues and cell types. Founded in 2021 and headquartered in Shanghai, China, RONA Therapeutics has raised $68M in Series A funding from investors including LongRiver Investments, BioTrack Capital, Lilly Asia Ventures, CMB International Capital, Fontus Capital, and LanTing Capital. The company employs 19 people and leverages advances in RNA chemistry and delivery technology to develop therapeutics that can modulate gene expression with high specificity, addressing diseases where traditional small molecule and antibody drugs have limited efficacy.
Business model
Genomics > Applied Genomics > Clinical Genomics > Therapeutics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.